首页 > 最新文献

World Journal of Clinical Cases最新文献

英文 中文
Streptococcus bovis endocarditis secondary to colorectal cancer: A case report. 结直肠癌继发牛链球菌心内膜炎1例。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-26 DOI: 10.12998/wjcc.v14.i3.117276
Kyle Nguyen-Ngo, Vinit H Majmudar, Aryan Jain, Nihita Manem, Katherine Donovan, Micheal Tadros

Background: Streptococcus bovis (S. bovis) bacteremia and infective endocarditis have a well-established association with colorectal cancer (CRC), though the mechanisms underlying this potentially bidirectional relationship remain poorly understood.

Case summary: This case report describes a 55-year-old male with a history of hypertension and hemicolectomy due to advanced colorectal adenomas who presented with syncope, septic shock, and a 12-pound weight loss over 3 weeks. Subsequent blood cultures grew S. bovis, with a transthoracic echocardiogram revealed mobile vegetations on both the aortic and mitral valves. A sessile, non-obstructing cecal adenocarcinoma was also observed on colonoscopy. The patient was started on 6 weeks of intravenous ceftriaxone, followed by surgical repair of both heart valves and a laparoscopic right hemicolectomy.

Conclusion: This presentation underscores how CRC-induced mucosal disruption may predispose to bacterial translocation, resulting in systemic infection and endocarditis.

背景:牛链球菌(S. bovis)菌血症和感染性心内膜炎与结直肠癌(CRC)有明确的关联,尽管这种潜在双向关系的机制尚不清楚。病例总结:本病例报告描述了一名55岁男性,因晚期结直肠腺瘤而有高血压和半结肠切除术史,表现为晕厥、感染性休克和3周内体重减轻12磅。随后的血培养培养为牛链球菌,经胸超声心动图显示主动脉瓣和二尖瓣上有可移动的植被。结肠镜检查也发现了一种无梗、无阻塞的盲肠腺癌。患者开始6周静脉注射头孢曲松,随后手术修复两个心脏瓣膜和腹腔镜右半结肠切除术。结论:本报告强调了crc诱导的粘膜破坏可能导致细菌易位,导致全身感染和心内膜炎。
{"title":"<i>Streptococcus bovis</i> endocarditis secondary to colorectal cancer: A case report.","authors":"Kyle Nguyen-Ngo, Vinit H Majmudar, Aryan Jain, Nihita Manem, Katherine Donovan, Micheal Tadros","doi":"10.12998/wjcc.v14.i3.117276","DOIUrl":"https://doi.org/10.12998/wjcc.v14.i3.117276","url":null,"abstract":"<p><strong>Background: </strong><i>Streptococcus bovis</i> (<i>S. bovis</i>) bacteremia and infective endocarditis have a well-established association with colorectal cancer (CRC), though the mechanisms underlying this potentially bidirectional relationship remain poorly understood.</p><p><strong>Case summary: </strong>This case report describes a 55-year-old male with a history of hypertension and hemicolectomy due to advanced colorectal adenomas who presented with syncope, septic shock, and a 12-pound weight loss over 3 weeks. Subsequent blood cultures grew <i>S. bovis</i>, with a transthoracic echocardiogram revealed mobile vegetations on both the aortic and mitral valves. A sessile, non-obstructing cecal adenocarcinoma was also observed on colonoscopy. The patient was started on 6 weeks of intravenous ceftriaxone, followed by surgical repair of both heart valves and a laparoscopic right hemicolectomy.</p><p><strong>Conclusion: </strong>This presentation underscores how CRC-induced mucosal disruption may predispose to bacterial translocation, resulting in systemic infection and endocarditis.</p>","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":"14 3","pages":"117276"},"PeriodicalIF":1.0,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12836038/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146093522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aloe-derived micellar emulsion dressing combination therapy for pressure ulcers: A case report and review of literature. 芦荟胶束乳剂敷料联合治疗压疮1例报告及文献复习。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-26 DOI: 10.12998/wjcc.v14.i3.113275
Shu-Ting Mei, Lu Li, Jie-Jing Li

Background: The management of stage IV pressure ulcers (PUs) in elderly, high-risk surgical patients remains a formidable clinical challenge, often limited by the invasiveness and risks of standard surgical options. Although Aloe vera has known wound-healing properties, clinical evidence of its efficacy in complex, severe PUs is scarce. This case report details a novel, non-invasive combination therapy centered around an aloe-derived micellar emulsion dressing (Aloe vera barbadensis extract R, AVBER) and demonstrates its potential as a viable palliative strategy for this vulnerable population.

Case summary: A 90-year-old, severely malnourished female (body mass index 13.3 kg/m2) presented with extensive, bilateral stage IV ischial PUs following a femoral fracture. Given her frailty and high surgical risk, a conservative regimen was initiated. This regimen comprised the topical application of an AVBER dressing, targeted red light therapy, and intensive nutritional support, all guided through telemedicine. Over a period of 8.5 months, this treatment was associated with complete healing of the left ulcer and near-complete resolution (from 15 cm × 15 cm to 0.8 cm × 3.0 cm) of the right ulcer, with no serious adverse events reported. The PU scale for healing score for the right ischial ulcer decreased markedly from 17 to 6.

Conclusion: AVBER-based combination therapy represents a promising non-invasive option for managing severe PUs in surgically ineligible patients.

背景:老年人高风险手术患者IV期压疮(PUs)的处理仍然是一个巨大的临床挑战,通常受到标准手术选择的侵入性和风险的限制。虽然芦荟具有已知的伤口愈合特性,但临床证据表明其对复杂,严重脓液的疗效很少。本病例报告详细介绍了一种以芦荟胶束乳液敷料(芦荟提取物R, AVBER)为中心的新型非侵入性联合治疗,并展示了其作为这一弱势群体可行的姑息策略的潜力。病例总结:一名90岁,严重营养不良的女性(体重指数13.3 kg/m2),在股骨骨折后出现广泛的双侧IV期坐骨脓液。鉴于她身体虚弱,手术风险高,我们开始了保守治疗。该方案包括局部应用AVBER敷料,靶向红光治疗和强化营养支持,所有这些都通过远程医疗指导。在8.5个月的时间里,这种治疗与左侧溃疡完全愈合和右侧溃疡几乎完全消退(从15cm × 15cm到0.8 cm × 3.0 cm)相关,没有严重的不良事件报告。右侧坐骨溃疡愈合评分PU由17分明显下降至6分。结论:以avber为基础的联合治疗是治疗不符合手术条件的严重脓毒症患者的一种有希望的非侵入性选择。
{"title":"Aloe-derived micellar emulsion dressing combination therapy for pressure ulcers: A case report and review of literature.","authors":"Shu-Ting Mei, Lu Li, Jie-Jing Li","doi":"10.12998/wjcc.v14.i3.113275","DOIUrl":"https://doi.org/10.12998/wjcc.v14.i3.113275","url":null,"abstract":"<p><strong>Background: </strong>The management of stage IV pressure ulcers (PUs) in elderly, high-risk surgical patients remains a formidable clinical challenge, often limited by the invasiveness and risks of standard surgical options. Although <i>Aloe vera</i> has known wound-healing properties, clinical evidence of its efficacy in complex, severe PUs is scarce. This case report details a novel, non-invasive combination therapy centered around an aloe-derived micellar emulsion dressing (<i>Aloe vera barbadensis</i> extract R, AVBER) and demonstrates its potential as a viable palliative strategy for this vulnerable population.</p><p><strong>Case summary: </strong>A 90-year-old, severely malnourished female (body mass index 13.3 kg/m<sup>2</sup>) presented with extensive, bilateral stage IV ischial PUs following a femoral fracture. Given her frailty and high surgical risk, a conservative regimen was initiated. This regimen comprised the topical application of an AVBER dressing, targeted red light therapy, and intensive nutritional support, all guided through telemedicine. Over a period of 8.5 months, this treatment was associated with complete healing of the left ulcer and near-complete resolution (from 15 cm × 15 cm to 0.8 cm × 3.0 cm) of the right ulcer, with no serious adverse events reported. The PU scale for healing score for the right ischial ulcer decreased markedly from 17 to 6.</p><p><strong>Conclusion: </strong>AVBER-based combination therapy represents a promising non-invasive option for managing severe PUs in surgically ineligible patients.</p>","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":"14 3","pages":"113275"},"PeriodicalIF":1.0,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12836083/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146093479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Primary splenic histiocytic sarcoma: A case report and review of literature. 原发性脾组织细胞肉瘤1例并文献复习。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-26 DOI: 10.12998/wjcc.v14.i3.116125
Zhi-Dong Jia, Cheng-Yan Zhang, Sheng-Zhi Liang, Hai-Liang Li

Background: Histiocytic sarcoma (HS) is a rare lymphohematopoietic malignancy with nonspecific clinical manifestations, diagnostic challenges, high aggressiveness, and a poor prognosis. Primary HSs arising in the spleen are extremely uncommon, with few cases reported globally. Here, we present the clinical course of a patient with splenic HS.

Case summary: A 67-year-old woman was admitted to our hospital because of a large splenic mass that was detected during a routine health examination 1 month before presentation. Abdominal computed tomography revealed a large occupying lesion in the spleen, which was possibly a lymphangioma. The patient underwent splenectomy, and postoperative pathological examination confirmed the diagnosis of splenic HS. At the 6-month telephonic follow-up, the patient reported feeling well.

Conclusion: Given the paucity of cases and the poor prognosis of splenic HS, whose definitive diagnosis hinges exclusively on pathology, and given that all current therapeutic strategies are based on isolated case reports, it is imperative to enhance our understanding of this disease to improve patient diagnosis and management.

背景:组织细胞肉瘤(HS)是一种罕见的淋巴造血恶性肿瘤,临床表现非特异性,诊断困难,侵袭性高,预后差。原发性HSs发生在脾脏是非常罕见的,在全球范围内报道的病例很少。在此,我们报告一位脾HS患者的临床过程。病例总结:一名67岁女性因在就诊前1个月的常规健康检查中发现一大块脾肿块而入院。腹部计算机断层扫描显示脾脏有一大块占位性病变,可能为淋巴管瘤。患者行脾切除术,术后病理检查确诊为脾HS。在6个月的电话随访中,患者报告感觉良好。结论:鉴于脾HS病例少,预后差,其最终诊断完全依赖于病理,目前所有的治疗策略都是基于孤立的病例报告,我们必须加强对该病的认识,以提高患者的诊断和治疗。
{"title":"Primary splenic histiocytic sarcoma: A case report and review of literature.","authors":"Zhi-Dong Jia, Cheng-Yan Zhang, Sheng-Zhi Liang, Hai-Liang Li","doi":"10.12998/wjcc.v14.i3.116125","DOIUrl":"https://doi.org/10.12998/wjcc.v14.i3.116125","url":null,"abstract":"<p><strong>Background: </strong>Histiocytic sarcoma (HS) is a rare lymphohematopoietic malignancy with nonspecific clinical manifestations, diagnostic challenges, high aggressiveness, and a poor prognosis. Primary HSs arising in the spleen are extremely uncommon, with few cases reported globally. Here, we present the clinical course of a patient with splenic HS.</p><p><strong>Case summary: </strong>A 67-year-old woman was admitted to our hospital because of a large splenic mass that was detected during a routine health examination 1 month before presentation. Abdominal computed tomography revealed a large occupying lesion in the spleen, which was possibly a lymphangioma. The patient underwent splenectomy, and postoperative pathological examination confirmed the diagnosis of splenic HS. At the 6-month telephonic follow-up, the patient reported feeling well.</p><p><strong>Conclusion: </strong>Given the paucity of cases and the poor prognosis of splenic HS, whose definitive diagnosis hinges exclusively on pathology, and given that all current therapeutic strategies are based on isolated case reports, it is imperative to enhance our understanding of this disease to improve patient diagnosis and management.</p>","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":"14 3","pages":"116125"},"PeriodicalIF":1.0,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12836014/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146094097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sphenopalatine ganglion block for postdural puncture headache: A review of current evidence. 蝶腭神经节阻滞治疗硬脊膜穿刺后头痛:当前证据综述。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-26 DOI: 10.12998/wjcc.v14.i3.114521
Pratap Rudra Mahanty, Biswajit Sen, Rishi Anand, Deb Sanjay Nag, Nirakar Pahadi, Dona Lodh, Tinali Upadhyaya

Background: Postdural puncture headache (PDPH) is a significant complication of neuraxial procedures. Although conservative treatments and the invasive epidural blood patch (EBP) are currently standard approaches, the sphenopalatine ganglion (SPG) block is emerging as a promising, less-invasive alternative. The pathophysiology of PDPH involves cerebrospinal fluid leakage, resulting in reduced intracranial pressure and compensatory cerebral vasodilation, which is partially mediated by SPG stimulation. The SPG block aims to interrupt this vasodilation using local anesthetics, thereby alleviating headache symptoms.

Aim: To provide a comprehensive overview of current evidence regarding the use of the SPG block in treating PDPH, explores the anatomical and physiological basis of this intervention, describes various administration techniques for administering the block, and critically assesses the efficacy and safety data from clinical studies.

Methods: A systematic literature search was conducted on PubMed and the Cochrane Database to identify systematic reviews and meta-analyses published up to April 2025, using the keywords "sphenopalatine ganglion block" and "post-dural puncture headache".

Results: The SPG block is a simple, noninvasive, and effective bedside procedure. Clinical studies have demonstrated that it provides rapid pain relief, with high success rates and an onset of action typically within 10-30 minutes. The most used technique is the transnasal approach, which is associated with minimal and transient adverse effects such as nasal discomfort and bitter taste.

Conclusion: Although EBP remains the preferred treatment for severe PDPH, the SPG block is a viable alternative for mild-to-moderate cases, often allowing patients to postpone or avoid EBP. Comparative studies suggest that SPG block has a quicker onset than EBP, though in some cases, it provides shorter duration relief. Overall, the SPG block is a safe, effective, and readily accessible treatment for PDPH. Its minimally invasive nature and high success rate in providing rapid pain relief make it an excellent first-line alternative to more invasive procedures. Further large-scale, standardized randomized controlled trials are required to optimize protocols and fully integrate the SPG block into mainstream clinical practice.

背景:硬脊膜后穿刺头痛(PDPH)是轴突手术的重要并发症。虽然保守治疗和侵入性硬膜外血贴(EBP)是目前的标准方法,但蝶帕神经节(SPG)阻滞正在成为一种有前途的、侵入性较低的替代方法。PDPH的病理生理涉及脑脊液漏,导致颅内压降低和代偿性脑血管舒张,部分由SPG刺激介导。SPG阻滞的目的是用局部麻醉剂阻断这种血管舒张,从而减轻头痛症状。目的:对目前使用SPG阻滞治疗PDPH的证据进行全面概述,探讨这种干预的解剖学和生理学基础,描述各种给药技术,并严格评估临床研究的有效性和安全性数据。方法:系统检索PubMed和Cochrane数据库,检索截至2025年4月发表的系统综述和荟萃分析,检索关键词为“蝶谷神经节阻滞”和“硬膜穿刺后头痛”。结果:SPG阻滞是一种简单、无创、有效的床边手术。临床研究表明,它能快速缓解疼痛,成功率高,通常在10-30分钟内起作用。最常用的技术是经鼻入路,它与轻微和短暂的不良反应有关,如鼻不适和苦味。结论:尽管EBP仍然是严重PDPH的首选治疗方法,但SPG阻滞对于轻至中度病例是一种可行的选择,通常允许患者推迟或避免EBP。比较研究表明,SPG阻滞比EBP起效更快,尽管在某些情况下,它提供的缓解时间更短。总的来说,SPG阻滞是一种安全、有效、容易获得的治疗PDPH的方法。它的微创性和在提供快速疼痛缓解方面的高成功率使其成为更有创手术的优秀一线替代方案。需要进一步的大规模、标准化的随机对照试验来优化方案,并将SPG阻滞完全纳入主流临床实践。
{"title":"Sphenopalatine ganglion block for postdural puncture headache: A review of current evidence.","authors":"Pratap Rudra Mahanty, Biswajit Sen, Rishi Anand, Deb Sanjay Nag, Nirakar Pahadi, Dona Lodh, Tinali Upadhyaya","doi":"10.12998/wjcc.v14.i3.114521","DOIUrl":"https://doi.org/10.12998/wjcc.v14.i3.114521","url":null,"abstract":"<p><strong>Background: </strong>Postdural puncture headache (PDPH) is a significant complication of neuraxial procedures. Although conservative treatments and the invasive epidural blood patch (EBP) are currently standard approaches, the sphenopalatine ganglion (SPG) block is emerging as a promising, less-invasive alternative. The pathophysiology of PDPH involves cerebrospinal fluid leakage, resulting in reduced intracranial pressure and compensatory cerebral vasodilation, which is partially mediated by SPG stimulation. The SPG block aims to interrupt this vasodilation using local anesthetics, thereby alleviating headache symptoms.</p><p><strong>Aim: </strong>To provide a comprehensive overview of current evidence regarding the use of the SPG block in treating PDPH, explores the anatomical and physiological basis of this intervention, describes various administration techniques for administering the block, and critically assesses the efficacy and safety data from clinical studies<b>.</b></p><p><strong>Methods: </strong>A systematic literature search was conducted on PubMed and the Cochrane Database to identify systematic reviews and meta-analyses published up to April 2025, using the keywords \"sphenopalatine ganglion block\" and \"post-dural puncture headache\".</p><p><strong>Results: </strong>The SPG block is a simple, noninvasive, and effective bedside procedure. Clinical studies have demonstrated that it provides rapid pain relief, with high success rates and an onset of action typically within 10-30 minutes. The most used technique is the transnasal approach, which is associated with minimal and transient adverse effects such as nasal discomfort and bitter taste.</p><p><strong>Conclusion: </strong>Although EBP remains the preferred treatment for severe PDPH, the SPG block is a viable alternative for mild-to-moderate cases, often allowing patients to postpone or avoid EBP. Comparative studies suggest that SPG block has a quicker onset than EBP, though in some cases, it provides shorter duration relief. Overall, the SPG block is a safe, effective, and readily accessible treatment for PDPH. Its minimally invasive nature and high success rate in providing rapid pain relief make it an excellent first-line alternative to more invasive procedures. Further large-scale, standardized randomized controlled trials are required to optimize protocols and fully integrate the SPG block into mainstream clinical practice.</p>","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":"14 3","pages":"114521"},"PeriodicalIF":1.0,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12836047/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146094169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early intervention in anxiety disorder patients with clinical high-risk factors for bipolar disorder: A randomized controlled trial. 具有双相情感障碍临床高危因素的焦虑症患者的早期干预:一项随机对照试验
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-26 DOI: 10.12998/wjcc.v14.i3.114691
Hong Wang, Shi-Liang Wang, Chen-Jie Ge, Li-Lei Lei, Lei Zeng, Min-Cai Qian
<p><strong>Background: </strong>Anxiety disorders are highly prevalent in patients with bipolar disorder (BD) and are associated with a more severe illness course and poorer outcomes. A significant clinical challenge is the frequent initial misdiagnosis of BD as anxiety, leading to prolonged diagnostic delays and suboptimal treatment. Growing evidence suggests that early intervention in individuals at high risk for BD can improve prognosis. Established clinical high-risk factors include early onset, family history of BD, and subthreshold manic symptoms. This creates a clinical dilemma whereby the administration of first-line antidepressants (<i>e.g.</i>, sertraline) for anxiety is debated in patients with a bipolar diathesis, given the associated risk of mood destabilization. Conversely, mood stabilizers like lithium are foundational in BD treatment, but their role in treating anxiety in high-risk populations is unproven. Therefore, we conducted this randomized controlled trial to evaluate whether early intervention with a combination of sertraline and lithium is more effective than sertraline monotherapy for anxiety disorder patients with clinical high-risk factors for BD.</p><p><strong>Aim: </strong>To investigate whether early intervention has a more positive outcome for anxiety disorders in patients who present with clinical high risk factors for BD.</p><p><strong>Methods: </strong>A total of 66 patients were enrolled in this study from January 2021 and December 2022 in Huzhou Third Municipal Hospital. They were randomly assigned to two groups to receive either an antidepressant (sertraline, <i>n</i> = 32) or a combination therapy (sertraline and lithium, <i>n</i> = 34). The main variables included alterations in Hamilton Anxiety Rating Scale and Hamilton Depression Rating Scale scores from the initial assessment to the final evaluation. A thorough combined Wald test was conducted to examine the intention-to-treat differences in scale assessment across treatment and time conditions.</p><p><strong>Results: </strong>Significant differences in the change of Hamilton Anxiety Rating Scale scores were observed between the two groups at week 1, week 2, and week 4 (<i>P</i> < 0.05). However, after 8 weeks and 12 weeks of treatment, there were no significant different (<i>P</i> = 0.485 and <i>P</i> = 0.206). There was no significant difference in the change over time in Hamilton Depression Rating Scale scores between the treatment groups (<i>P</i> = 0.2), except at week 12 (<i>P</i> = 0.034). No significant differences were observed in the adverse effects reported between patients treated with sertraline alone (18%) and those treated with the combination therapy (21%).</p><p><strong>Conclusion: </strong>This current double-blind, case-controlled study assessed the effectiveness and tolerability of combined therapy <i>vs</i> monotherapy for anxiety disorder in patients with clinical high-risk factors for BD. In light of the constraints associated with
背景:焦虑障碍在双相情感障碍(BD)患者中非常普遍,并且与更严重的病程和更差的预后相关。一个重要的临床挑战是经常将双相障碍误诊为焦虑,导致长时间的诊断延误和不理想的治疗。越来越多的证据表明,对双相障碍高危人群进行早期干预可以改善预后。确定的临床高危因素包括早发、双相障碍家族史和阈下躁狂症状。这就造成了一个临床困境,即在双相素质患者中,考虑到相关的情绪不稳定风险,一线抗抑郁药(例如舍曲林)治疗焦虑的管理存在争议。相反,像锂这样的情绪稳定剂是双相障碍治疗的基础,但它们在治疗高风险人群焦虑方面的作用尚未得到证实。因此,我们进行了这项随机对照试验,以评估早期干预舍曲林和锂联合治疗是否比单药治疗更有效。目的:探讨早期干预是否对存在临床bd高危因素的焦虑障碍患者有更积极的结果。本研究于2021年1月至2022年12月在湖州市第三市立医院共纳入66例患者。他们被随机分为两组,接受抗抑郁药(舍曲林,n = 32)或联合治疗(舍曲林和锂,n = 34)。主要变量包括汉米尔顿焦虑评定量表和汉米尔顿抑郁评定量表得分从最初评估到最终评估的变化。进行了全面的联合Wald检验,以检查治疗和时间条件下量表评估的治疗意向差异。结果:两组患者在第1周、第2周、第4周汉密尔顿焦虑评定量表得分变化差异有统计学意义(P < 0.05)。治疗8周和12周后,两组间差异无统计学意义(P = 0.485和P = 0.206)。汉密尔顿抑郁评定量表评分随时间的变化在治疗组之间无显著差异(P = 0.2),除了第12周(P = 0.034)。单独使用舍曲林(18%)和联合使用舍曲林(21%)的患者报告的不良反应没有显著差异。结论:目前这项双盲、病例对照研究评估了联合治疗与单一治疗对具有BD临床高危因素患者焦虑障碍的有效性和耐受性。鉴于本初步研究的局限性,结果表明舍曲林和锂联合治疗可能提供更有利的预后。
{"title":"Early intervention in anxiety disorder patients with clinical high-risk factors for bipolar disorder: A randomized controlled trial.","authors":"Hong Wang, Shi-Liang Wang, Chen-Jie Ge, Li-Lei Lei, Lei Zeng, Min-Cai Qian","doi":"10.12998/wjcc.v14.i3.114691","DOIUrl":"https://doi.org/10.12998/wjcc.v14.i3.114691","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Anxiety disorders are highly prevalent in patients with bipolar disorder (BD) and are associated with a more severe illness course and poorer outcomes. A significant clinical challenge is the frequent initial misdiagnosis of BD as anxiety, leading to prolonged diagnostic delays and suboptimal treatment. Growing evidence suggests that early intervention in individuals at high risk for BD can improve prognosis. Established clinical high-risk factors include early onset, family history of BD, and subthreshold manic symptoms. This creates a clinical dilemma whereby the administration of first-line antidepressants (&lt;i&gt;e.g.&lt;/i&gt;, sertraline) for anxiety is debated in patients with a bipolar diathesis, given the associated risk of mood destabilization. Conversely, mood stabilizers like lithium are foundational in BD treatment, but their role in treating anxiety in high-risk populations is unproven. Therefore, we conducted this randomized controlled trial to evaluate whether early intervention with a combination of sertraline and lithium is more effective than sertraline monotherapy for anxiety disorder patients with clinical high-risk factors for BD.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Aim: &lt;/strong&gt;To investigate whether early intervention has a more positive outcome for anxiety disorders in patients who present with clinical high risk factors for BD.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;A total of 66 patients were enrolled in this study from January 2021 and December 2022 in Huzhou Third Municipal Hospital. They were randomly assigned to two groups to receive either an antidepressant (sertraline, &lt;i&gt;n&lt;/i&gt; = 32) or a combination therapy (sertraline and lithium, &lt;i&gt;n&lt;/i&gt; = 34). The main variables included alterations in Hamilton Anxiety Rating Scale and Hamilton Depression Rating Scale scores from the initial assessment to the final evaluation. A thorough combined Wald test was conducted to examine the intention-to-treat differences in scale assessment across treatment and time conditions.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;Significant differences in the change of Hamilton Anxiety Rating Scale scores were observed between the two groups at week 1, week 2, and week 4 (&lt;i&gt;P&lt;/i&gt; &lt; 0.05). However, after 8 weeks and 12 weeks of treatment, there were no significant different (&lt;i&gt;P&lt;/i&gt; = 0.485 and &lt;i&gt;P&lt;/i&gt; = 0.206). There was no significant difference in the change over time in Hamilton Depression Rating Scale scores between the treatment groups (&lt;i&gt;P&lt;/i&gt; = 0.2), except at week 12 (&lt;i&gt;P&lt;/i&gt; = 0.034). No significant differences were observed in the adverse effects reported between patients treated with sertraline alone (18%) and those treated with the combination therapy (21%).&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;This current double-blind, case-controlled study assessed the effectiveness and tolerability of combined therapy &lt;i&gt;vs&lt;/i&gt; monotherapy for anxiety disorder in patients with clinical high-risk factors for BD. In light of the constraints associated with ","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":"14 3","pages":"114691"},"PeriodicalIF":1.0,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12836058/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146094108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cachexia as an unusual presentation of familial Mediterranean fever: A case report. 恶病质是家族性地中海热的一种不寻常表现:1例报告。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-26 DOI: 10.12998/wjcc.v14.i3.117165
Ahmed Mostafa Sira, Samar Ahmed Shoeir, Mostafa Mohamed Sira

Background: Familial Mediterranean fever (FMF) is the most common autoinflammatory disease, characterized by uncontrolled activation of the innate immune system that manifests as recurrent fever and polyserositis (e.g., peritonitis, pleuritis, and arthritis). However, diagnosing atypical cases remains challenging.

Case summary: A 9-year-old girl had a history of progressive loss of appetite, weight loss, and myalgia over the preceding three months. She developed high-grade fever over the preceding three weeks, occasionally associated with abdominal pain. The girl is one of a triplet; neither of the other two sisters had similar symptoms. Family history was irrelevant. She presented with cachexia, generalized body aches, and fever without evident arthritis. She had splenomegaly and a markedly elevated erythrocyte sedimentation rate. After exclusion of rheumatological and malignant causes, FMF was suspected. Serum amyloid A was high. The patient received colchicine therapy. There was a significant improvement in her symptoms with normalization of acute-phase reactants. Polymerase chain reaction test for FMF gene mutation returned negative.

Conclusion: FMF can present with atypical symptoms. Detailed history and meticulous clinical evaluation were key clues suggesting the diagnosis.

背景:家族性地中海热(FMF)是最常见的自身炎症性疾病,其特征是先天免疫系统不受控制的激活,表现为反复发热和多血清炎(如腹膜炎、胸膜炎和关节炎)。然而,诊断非典型病例仍然具有挑战性。病例总结:一名9岁女孩在前三个月有进行性食欲减退、体重减轻和肌痛的病史。她在前三周出现高热,偶尔伴有腹痛。这个女孩是三胞胎中的一个;另外两姐妹都没有类似的症状。家族史无关紧要。患者表现为恶病质、全身疼痛和发热,无明显关节炎。她脾肿大,红细胞沉降率明显升高。排除风湿及恶性原因后,怀疑为FMF。血清淀粉样蛋白A高。患者接受秋水仙碱治疗。急性期反应物正常化后,她的症状有了显著改善。FMF基因突变聚合酶链反应试验阴性。结论:FMF可表现为非典型症状。详细的病史和细致的临床评价是提示诊断的关键线索。
{"title":"Cachexia as an unusual presentation of familial Mediterranean fever: A case report.","authors":"Ahmed Mostafa Sira, Samar Ahmed Shoeir, Mostafa Mohamed Sira","doi":"10.12998/wjcc.v14.i3.117165","DOIUrl":"https://doi.org/10.12998/wjcc.v14.i3.117165","url":null,"abstract":"<p><strong>Background: </strong>Familial Mediterranean fever (FMF) is the most common autoinflammatory disease, characterized by uncontrolled activation of the innate immune system that manifests as recurrent fever and polyserositis (<i>e.g.</i>, peritonitis, pleuritis, and arthritis). However, diagnosing atypical cases remains challenging.</p><p><strong>Case summary: </strong>A 9-year-old girl had a history of progressive loss of appetite, weight loss, and myalgia over the preceding three months. She developed high-grade fever over the preceding three weeks, occasionally associated with abdominal pain. The girl is one of a triplet; neither of the other two sisters had similar symptoms. Family history was irrelevant. She presented with cachexia, generalized body aches, and fever without evident arthritis. She had splenomegaly and a markedly elevated erythrocyte sedimentation rate. After exclusion of rheumatological and malignant causes, FMF was suspected. Serum amyloid A was high. The patient received colchicine therapy. There was a significant improvement in her symptoms with normalization of acute-phase reactants. Polymerase chain reaction test for <i>FMF</i> gene mutation returned negative.</p><p><strong>Conclusion: </strong>FMF can present with atypical symptoms. Detailed history and meticulous clinical evaluation were key clues suggesting the diagnosis.</p>","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":"14 3","pages":"117165"},"PeriodicalIF":1.0,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12836049/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146093448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ocular health in outer space and beyond gravity: A minireview. 外太空和重力之外的眼健康:综述。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-26 DOI: 10.12998/wjcc.v14.i3.117257
Srishti Khullar, Arvind Kumar Morya, Sarita Aggarwal, Twinkle Gupta, Priyanka Priyanka, Rannusha Morya

Prolonged exposure to microgravity profoundly influences ocular physiology, giving rise to spaceflight-associated neuro-ocular syndrome (SANS), a significant concern for astronauts on long-duration missions. This review consolidates current evidence on ocular adaptations to spaceflight, encompassing pathophysiological mechanisms, diagnostic advances, related ocular conditions, and emerging countermeasures. Literature published between 2000 and 2025 was systematically examined across PubMed, Scopus, and Web of Science, integrating both peer-reviewed studies and technical reports from the National Aeronautics and Space Administration and the European Space Agency. Findings indicate that ocular changes consistent with SANS affect approximately one-third of astronauts, with higher prevalence during missions exceeding six months. Hallmark features include optic disc edema, posterior globe flattening, and mild hyperopic shifts, attributed to cephalad fluid shifts, altered cerebrospinal fluid dynamics, venous congestion, and impaired glymphatic flow. Besides SANS, microgravity predisposes astronauts to dry eye disease, immune-related infections, and radiation-induced cataracts. Recent advances in in-flight optical coherence tomography, optical coherence tomography angiography, and ultrasound have enhanced early detection, while countermeasures such as lower body negative pressure, artificial gravity, and artificial intelligence-driven ocular monitoring show promise. Understanding ocular adaptations to space not only mitigates mission risks but also enriches terrestrial knowledge of intracranial pressure regulation and neuro-ophthalmic health.

长期暴露于微重力环境对眼部生理产生深远影响,导致与航天飞行相关的神经-眼综合征,这是执行长期任务的宇航员所关心的一个重大问题。这篇综述整合了目前关于眼部适应太空飞行的证据,包括病理生理机制、诊断进展、相关眼部疾病和新出现的对策。2000年至2025年间发表的文献在PubMed、Scopus和Web of Science上进行了系统的检查,整合了同行评审的研究和来自美国国家航空航天局和欧洲航天局的技术报告。调查结果表明,与SANS相符的眼部变化影响了大约三分之一的宇航员,在超过六个月的任务期间患病率更高。标志性特征包括视盘水肿、后球变平和轻度远视移位,这是由头液移位、脑脊液动力学改变、静脉充血和淋巴血流受损引起的。除了SANS,微重力还会使宇航员容易患上干眼病、免疫相关感染和辐射诱发的白内障。最近在飞行光学相干断层扫描、光学相干断层扫描血管造影和超声方面的进展增强了早期检测,而下体负压、人工重力和人工智能驱动的眼监测等对策也有希望。了解眼部对空间的适应不仅可以减轻任务风险,还可以丰富地面上对颅内压调节和神经眼健康的认识。
{"title":"Ocular health in outer space and beyond gravity: A minireview.","authors":"Srishti Khullar, Arvind Kumar Morya, Sarita Aggarwal, Twinkle Gupta, Priyanka Priyanka, Rannusha Morya","doi":"10.12998/wjcc.v14.i3.117257","DOIUrl":"https://doi.org/10.12998/wjcc.v14.i3.117257","url":null,"abstract":"<p><p>Prolonged exposure to microgravity profoundly influences ocular physiology, giving rise to spaceflight-associated neuro-ocular syndrome (SANS), a significant concern for astronauts on long-duration missions. This review consolidates current evidence on ocular adaptations to spaceflight, encompassing pathophysiological mechanisms, diagnostic advances, related ocular conditions, and emerging countermeasures. Literature published between 2000 and 2025 was systematically examined across PubMed, Scopus, and Web of Science, integrating both peer-reviewed studies and technical reports from the National Aeronautics and Space Administration and the European Space Agency. Findings indicate that ocular changes consistent with SANS affect approximately one-third of astronauts, with higher prevalence during missions exceeding six months. Hallmark features include optic disc edema, posterior globe flattening, and mild hyperopic shifts, attributed to cephalad fluid shifts, altered cerebrospinal fluid dynamics, venous congestion, and impaired glymphatic flow. Besides SANS, microgravity predisposes astronauts to dry eye disease, immune-related infections, and radiation-induced cataracts. Recent advances in in-flight optical coherence tomography, optical coherence tomography angiography, and ultrasound have enhanced early detection, while countermeasures such as lower body negative pressure, artificial gravity, and artificial intelligence-driven ocular monitoring show promise. Understanding ocular adaptations to space not only mitigates mission risks but also enriches terrestrial knowledge of intracranial pressure regulation and neuro-ophthalmic health.</p>","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":"14 3","pages":"117257"},"PeriodicalIF":1.0,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12835991/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146094047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnostic perspectives on mixed connective tissue disease with tuberculosis overlap. 混合性结缔组织病合并结核重叠的诊断观点。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-26 DOI: 10.12998/wjcc.v14.i3.117076
Shree V Dhotre, Pradnya S Dhotre, Ajay M Gavkare, Basavraj S Nagoba

The recently published case report describing mixed connective tissue disease coexisting with tuberculosis (TB) provides an important contribution to the growing literature on complex autoimmune-infectious disease interactions. This letter expands on the diagnostic challenges highlighted by the authors by defining its added clinical value: Identifying practical diagnostic "red flags", emphasizing parallel consideration of autoimmunity and infection, and proposing a pragmatic approach to evaluation in TB-endemic settings. Early immunological testing, differentiated pulmonary assessment, and multidisciplinary decision-making are essential when overlapping features obscure timely diagnosis and complicate therapeutic choices.

最近发表的关于混合性结缔组织病与结核病(TB)共存的病例报告为越来越多的关于复杂自身免疫-感染性疾病相互作用的文献提供了重要贡献。这封信通过定义其附加的临床价值,扩展了作者强调的诊断挑战:确定实用的诊断“危险信号”,强调同时考虑自身免疫和感染,并提出在结核病流行环境中进行评估的实用方法。当重叠的特征模糊了及时诊断和使治疗选择复杂化时,早期免疫检测、鉴别肺评估和多学科决策是必不可少的。
{"title":"Diagnostic perspectives on mixed connective tissue disease with tuberculosis overlap.","authors":"Shree V Dhotre, Pradnya S Dhotre, Ajay M Gavkare, Basavraj S Nagoba","doi":"10.12998/wjcc.v14.i3.117076","DOIUrl":"https://doi.org/10.12998/wjcc.v14.i3.117076","url":null,"abstract":"<p><p>The recently published case report describing mixed connective tissue disease coexisting with tuberculosis (TB) provides an important contribution to the growing literature on complex autoimmune-infectious disease interactions. This letter expands on the diagnostic challenges highlighted by the authors by defining its added clinical value: Identifying practical diagnostic \"red flags\", emphasizing parallel consideration of autoimmunity and infection, and proposing a pragmatic approach to evaluation in TB-endemic settings. Early immunological testing, differentiated pulmonary assessment, and multidisciplinary decision-making are essential when overlapping features obscure timely diagnosis and complicate therapeutic choices.</p>","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":"14 3","pages":"117076"},"PeriodicalIF":1.0,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12836073/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146093842","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differentiating fenbendazole-induced liver injury from immunotherapy hepatitis - the importance of structured causality assessment: A case report. 区分非苯达唑引起的肝损伤与免疫治疗性肝炎——结构化因果关系评估的重要性:一个病例报告。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-16 DOI: 10.12998/wjcc.v14.i2.116700
Arunkumar Krishnan, Kaleb Lucas, Laura Maas, Tinsay A Woreta

Background: Drug-induced liver injury poses a diagnostic challenge in oncology patients, especially those on immune checkpoint inhibitors, because symptoms often overlap with immune-mediated hepatitis. The increasing use of social media has led people to self-administer veterinary anthelmintics like fenbendazole for cancer, often at high doses and without medical guidance, despite limited data on safety or effectiveness.

Case summary: We report a case of a 47-year-old woman with metastatic colon cancer on nivolumab/relatlimab who developed severe hepatocellular liver injury after increasing her self-administered dose of fenbendazole. A detailed medical and temporal history, supported by a Roussel Uclaf Causality Assessment Method score of 8 (probable), identified fenbendazole as the most likely cause. Rapid biochemical improvement occurred after stopping the drug, with safe reintroduction of immunotherapy and no recurrence of liver injury.

Conclusion: This case emphasizes the importance of thorough medication history-taking and structured causality assessment to distinguish between unregulated drug-induced liver injury and immune-related adverse events in cancer care. The use of social media to promote alternative therapies necessitates proactive patient counseling due to significant liver risks, and careful diagnostic evaluation can prevent unnecessary immunosuppression or treatment delays.

背景:药物性肝损伤对肿瘤患者的诊断提出了挑战,特别是那些使用免疫检查点抑制剂的患者,因为症状往往与免疫介导的肝炎重叠。越来越多地使用社交媒体,导致人们自行使用芬苯达唑等兽医驱虫剂治疗癌症,通常是高剂量的,而且没有医疗指导,尽管有关安全性或有效性的数据有限。病例总结:我们报告了一例47岁的女性转移性结肠癌患者,接受尼沃单抗/相对利单抗治疗,在增加自我给药剂量芬苯达唑后发生严重的肝细胞性肝损伤。根据Roussel Uclaf因果关系评估方法评分为8分(可能),详细的病史和时间史确定芬苯达唑是最可能的原因。停药后出现了快速的生化改善,安全的重新引入免疫治疗,没有肝损伤复发。结论:本病例强调了全面的用药史和结构化的因果关系评估的重要性,以区分癌症治疗中不规范的药物性肝损伤和免疫相关不良事件。使用社交媒体来推广替代疗法需要积极主动的患者咨询,因为它有显著的肝脏风险,仔细的诊断评估可以防止不必要的免疫抑制或治疗延误。
{"title":"Differentiating fenbendazole-induced liver injury from immunotherapy hepatitis - the importance of structured causality assessment: A case report.","authors":"Arunkumar Krishnan, Kaleb Lucas, Laura Maas, Tinsay A Woreta","doi":"10.12998/wjcc.v14.i2.116700","DOIUrl":"https://doi.org/10.12998/wjcc.v14.i2.116700","url":null,"abstract":"<p><strong>Background: </strong>Drug-induced liver injury poses a diagnostic challenge in oncology patients, especially those on immune checkpoint inhibitors, because symptoms often overlap with immune-mediated hepatitis. The increasing use of social media has led people to self-administer veterinary anthelmintics like fenbendazole for cancer, often at high doses and without medical guidance, despite limited data on safety or effectiveness.</p><p><strong>Case summary: </strong>We report a case of a 47-year-old woman with metastatic colon cancer on nivolumab/relatlimab who developed severe hepatocellular liver injury after increasing her self-administered dose of fenbendazole. A detailed medical and temporal history, supported by a Roussel Uclaf Causality Assessment Method score of 8 (probable), identified fenbendazole as the most likely cause. Rapid biochemical improvement occurred after stopping the drug, with safe reintroduction of immunotherapy and no recurrence of liver injury.</p><p><strong>Conclusion: </strong>This case emphasizes the importance of thorough medication history-taking and structured causality assessment to distinguish between unregulated drug-induced liver injury and immune-related adverse events in cancer care. The use of social media to promote alternative therapies necessitates proactive patient counseling due to significant liver risks, and careful diagnostic evaluation can prevent unnecessary immunosuppression or treatment delays.</p>","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":"14 2","pages":"116700"},"PeriodicalIF":1.0,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12836008/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146094429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Functional and aesthetic oral rehabilitation after cancer treatment using dental prosthesis and hyaluronic acid injections: A case report and review of literature. 使用义齿和透明质酸注射治疗癌症后的功能性和美观性口腔康复:1例报告及文献复习。
IF 1 4区 医学 Q3 MEDICINE, GENERAL & INTERNAL Pub Date : 2026-01-16 DOI: 10.12998/wjcc.v14.i2.110627
Nadège Hessloehl, Pierre-Yves Collart-Dutilleul, Olivier Romieu, Delphine Carayon

Background: Oral cavity cancers are highly invasive malignancies, typically treated with a combination of surgery, radiation, and chemotherapy. Surgical intervention requires the removal of all affected tissues, including the mandibular basal bone. Reconstructive procedures may involve tissue and skin grafts, such as fibula free flaps in the case of mandibulectomy. These techniques aim to minimize scarring and restore basic oral functions. However, radiation therapy may result in fibrotic scarring of the connective tissues. This case report focuses on the integration of surgical, prosthetic, and complementary therapies - including hyaluronic acid (HA) -based filler - to address both functional and aesthetic deficiencies.

Case summary: The case involves a 70-year-old woman who underwent a right segmental mandibulectomy with fibula free flap reconstruction for pT4aN2b oral squamous cell carcinoma, followed by adjuvant radiochemotherapy. After surgery, she presented to the Odontology Department of Montpellier University Hospital with severe trismus, impaired mastication, and aesthetic concerns, including marked facial atrophy and asymmetry of the face and mouth. The multidisciplinary approach included fluoride trays to address radiotherapy-induced risks, caries treatment, a mandibular partial removable prosthesis for occlusal and soft tissue support, occlusal bonding, and HA injections to restore facial symmetry and improve soft tissue quality. HA was injected into the fibrotic connective tissue to improve skin hydration and counterbalance the asymmetry of the mouth. The combination of prosthetic rehabilitation and HA injections led to significant functional and aesthetic improvements, with a notable positive impact on the patient's sociability and quality of life.

Conclusion: This case highlights how a multidisciplinary, comprehensive, personalized, and biopsychosocial approach can optimize outcomes in complex oral rehabilitation following oncological surgery.

背景:口腔癌是高度侵袭性的恶性肿瘤,通常采用手术、放疗和化疗联合治疗。手术干预需要去除所有受影响的组织,包括下颌基底骨。重建程序可能涉及组织和皮肤移植,如腓骨游离皮瓣在下颌骨切除术的情况下。这些技术的目的是尽量减少疤痕和恢复基本的口腔功能。然而,放射治疗可能导致结缔组织的纤维化瘢痕。本病例报告的重点是整合手术,假体和补充疗法-包括透明质酸(HA)为基础的填充物-以解决功能和美学缺陷。病例总结:该病例涉及一名70岁的女性,她因pT4aN2b口腔鳞状细胞癌接受了右节段下颌骨切除术和腓骨游离皮瓣重建,随后进行了辅助放化疗。手术后,她因严重的咬牙,咀嚼功能受损和美学问题,包括明显的面部萎缩和面部和口腔不对称,来到蒙彼利埃大学医院的齿科。多学科方法包括氟化物托盘以解决放疗引起的风险,龋齿治疗,下颌部分可移动假体用于咬合和软组织支持,咬合结合,以及HA注射以恢复面部对称性并改善软组织质量。将透明质酸注射到纤维化结缔组织中,以改善皮肤水合作用,平衡口腔的不对称。假体康复与HA注射相结合可显著改善患者的功能和美观,对患者的社交能力和生活质量有显著的积极影响。结论:本病例强调了多学科、综合、个性化和生物心理社会方法如何优化肿瘤手术后复杂口腔康复的结果。
{"title":"Functional and aesthetic oral rehabilitation after cancer treatment using dental prosthesis and hyaluronic acid injections: A case report and review of literature.","authors":"Nadège Hessloehl, Pierre-Yves Collart-Dutilleul, Olivier Romieu, Delphine Carayon","doi":"10.12998/wjcc.v14.i2.110627","DOIUrl":"https://doi.org/10.12998/wjcc.v14.i2.110627","url":null,"abstract":"<p><strong>Background: </strong>Oral cavity cancers are highly invasive malignancies, typically treated with a combination of surgery, radiation, and chemotherapy. Surgical intervention requires the removal of all affected tissues, including the mandibular basal bone. Reconstructive procedures may involve tissue and skin grafts, such as fibula free flaps in the case of mandibulectomy. These techniques aim to minimize scarring and restore basic oral functions. However, radiation therapy may result in fibrotic scarring of the connective tissues. This case report focuses on the integration of surgical, prosthetic, and complementary therapies - including hyaluronic acid (HA) -based filler - to address both functional and aesthetic deficiencies.</p><p><strong>Case summary: </strong>The case involves a 70-year-old woman who underwent a right segmental mandibulectomy with fibula free flap reconstruction for pT4aN2b oral squamous cell carcinoma, followed by adjuvant radiochemotherapy. After surgery, she presented to the Odontology Department of Montpellier University Hospital with severe trismus, impaired mastication, and aesthetic concerns, including marked facial atrophy and asymmetry of the face and mouth. The multidisciplinary approach included fluoride trays to address radiotherapy-induced risks, caries treatment, a mandibular partial removable prosthesis for occlusal and soft tissue support, occlusal bonding, and HA injections to restore facial symmetry and improve soft tissue quality. HA was injected into the fibrotic connective tissue to improve skin hydration and counterbalance the asymmetry of the mouth. The combination of prosthetic rehabilitation and HA injections led to significant functional and aesthetic improvements, with a notable positive impact on the patient's sociability and quality of life.</p><p><strong>Conclusion: </strong>This case highlights how a multidisciplinary, comprehensive, personalized, and biopsychosocial approach can optimize outcomes in complex oral rehabilitation following oncological surgery.</p>","PeriodicalId":23912,"journal":{"name":"World Journal of Clinical Cases","volume":"14 2","pages":"110627"},"PeriodicalIF":1.0,"publicationDate":"2026-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12836028/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146094494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
World Journal of Clinical Cases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1